Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Banihashemi SR, Es-Haghi A, Fallah Mehrabadi MH, Nofeli M, Mokarram AR, Ranjbar A, Salman M, Hajimoradi M, Razaz SH, Taghdiri M, Bagheri M, Dadar M, Hassan ZM, Eslampanah M, Salehi Najafabadi Z, Lotfi M, Khorasani A, Rahmani F. Banihashemi SR, et al. Among authors: taghdiri m. Front Immunol. 2022 May 26;13:836745. doi: 10.3389/fimmu.2022.836745. eCollection 2022. Front Immunol. 2022. PMID: 35693788 Free PMC article.
Comprehensive copy number analysis of spinal muscular atrophy among the Iranian population.
Khanbazi A, Beheshtian M, Azad M, Akbari Kelishomi M, Afroozan F, Fatehi F, Noudehi K, Zamanian Najafabadi S, Omrani M, Habibi H, Taghdiri M, Abdi Rad I, Nafissi S, Jankhah A, Yazdan H, Daneshmand P, Saberi SH, Kahrizi K, Kariminejad A, Najmabadi H. Khanbazi A, et al. Among authors: taghdiri m. Sci Rep. 2024 Dec 2;14(1):29880. doi: 10.1038/s41598-024-76815-x. Sci Rep. 2024. PMID: 39622884 Free PMC article.
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial.
Fallah Mehrabadi MH, Hajimoradi M, Es-Haghi A, Kalantari S, Noofeli M, Mokarram AR, Razzaz SH, Taghdiri M, Mokhberalsafa L, Sadeghi F, Mohseni V, Masoumi S, Golmoradi-Zadeh R, Rabiee MH, Solaymani-Dodaran M, Banihashemi SR. Fallah Mehrabadi MH, et al. Among authors: taghdiri m. Vaccines (Basel). 2024 Nov 5;12(11):1255. doi: 10.3390/vaccines12111255. Vaccines (Basel). 2024. PMID: 39591158 Free PMC article.
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial.
Solaymani-Dodaran M, Kalantari S, Banihashemi SR, Es-Haghi A, Nofeli M, Mohazzab A, Mokhberalsafa L, Sadeghi F, Mokaram AR, Moradi MH, Razaz SH, Taghdiri M, Lotfi M, Setarehdan SA, Masoumi S, Ansarifar A, Ebrahimi S, Esmailzadehha N, Boluki Z, Khoramdad M, Molaipour L, Rabiei MH, Amiri FB, Filsoof S, Bani-Vaheb B, Derakhshani MR, Bayazidi S, Golmoradizadeh R, Shahsavan M, Safari S, Ghahremanzadeh N, Mohseni V, Erfanpoor S, Fallah Mehrabadi MH. Solaymani-Dodaran M, et al. Among authors: taghdiri m. Heliyon. 2024 Mar 3;10(5):e27370. doi: 10.1016/j.heliyon.2024.e27370. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463808 Free PMC article.
62 results